Teleflex Incorporated (NYSE:TFX) Stake Lowered by Signaturefd LLC

Signaturefd LLC decreased its position in shares of Teleflex Incorporated (NYSE:TFX) by 38.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 313 shares of the medical technology company’s stock after selling 192 shares during the period. Signaturefd LLC’s holdings in Teleflex were worth $56,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Janus Henderson Group PLC grew its stake in shares of Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after buying an additional 147,147 shares in the last quarter. State Street Corp grew its position in Teleflex by 1.0% in the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after acquiring an additional 21,291 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock worth $278,676,000 after purchasing an additional 5,746 shares during the last quarter. Cooke & Bieler LP raised its holdings in shares of Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after purchasing an additional 195,150 shares in the last quarter. Finally, Point72 Asset Management L.P. lifted its stake in shares of Teleflex by 31.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock valued at $100,768,000 after purchasing an additional 96,958 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE:TFX opened at $141.62 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.91. The company has a fifty day moving average price of $162.43 and a 200 day moving average price of $192.97. The stock has a market cap of $6.57 billion, a P/E ratio of 28.16, a PEG ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.96%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s payout ratio is presently 95.77%.

Wall Street Analyst Weigh In

Several equities analysts have commented on TFX shares. Citizens Jmp downgraded shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. Wells Fargo & Company lowered their price target on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. Finally, Bank of America cut shares of Teleflex from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.